Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Gerber

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Drug Safety|July 1, 2024
Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza SeasonIgnacio Salamanca de la Cueva, Jennifer E Gerber, Andrew Hastie, et al.
Oral Oncology|June 23, 2015
Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT studyKaren S Anderson, Jennifer E Gerber, Gypsyamber D'Souza, et al.
BMJ Open|February 26, 2026
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping reviewTheodora Oikonomidi, Hanaya Raad, John Diaz-Decaro, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Drug Safety|July 1, 2024
Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza SeasonIgnacio Salamanca de la Cueva, Jennifer E Gerber, Andrew Hastie, et al.
Oral Oncology|June 23, 2015
Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT studyKaren S Anderson, Jennifer E Gerber, Gypsyamber D'Souza, et al.
BMJ Open|February 26, 2026
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping reviewTheodora Oikonomidi, Hanaya Raad, John Diaz-Decaro, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
Pageof 2